Poisonous Dengue Fever Vaccine created
The Unhived Mind
11 July 2014 Last updated at 02:25
http://www.bbc.co.uk/news/health-28243587
First dengue vaccine ‘shows promise’
By Smitha Mundasad Health reporter, BBC News
Scientists say they have developed the world’s first vaccine against dengue fever seen to work in large-scale trials.
Research in the Lancet journal suggests more than 50% of children who are given the vaccine are protected against the disease.
Half the world’s population are at risk of catching the mosquito-borne virus.
Experts say though the long-awaited study is promising, vaccines with greater effectiveness are crucial.
There are currently no treatments to prevent dengue fever – an illness which affects more than one million people a year.
‘Best so far’
In the largest late-stage trial of a vaccine to date, researchers from five centres across Asia treated 6,000 children aged between two and 14 years old.
Some 56% were seen to have protection against the virus at the end of two years.
It worked best for children with certain subtypes of the virus and those who had been exposed to it before.
And the vaccine had an even greater impact on severe forms of the disease, reducing the number of people needing treatment in hospital and preventing 80% of cases of haemorrhagic fever – a potentially life-threatening complication.
Lead author Dr Maria Rosario Capeding, from the Research Institute for Tropical Medicine in the Philippines, told the BBC: “Given that dengue is a major public health problem in most Asian countries the findings have the potential to have a huge impact on public health.
“A 56% reduction, though moderate, can translate into a huge benefit for countries plagued by the disease.”
‘Complex biology’
Prof Martin Hibberd of the London School of Hygiene and Topical Medicine who was not involved in the study said: “The biology of dengue is complex and has troubled researchers for many years.
“I am very glad they have tackled this, but I am disappointed the vaccine is only 56% effective – much lower than our normal targets.
“Nevertheless this is the most significant reduction we have seen to date – the best we have so far.
“And many nations spend huge amounts of money trying to prevent the spread of this disease.”
He suggests people who have been given the vaccine should be monitored for at least five years to ensure it remains effective and safe.
And further questions need to be addressed, including how much of an impact it will have in other parts of the world.
Sanofi-Pasteur, the company funding the research, plans to apply for approval once the results of its second trial across Latin America and the Caribbean have been analysed.
http://theunhivedmind.com/wordpress3/poisonous-dengue-fever-vaccine-created/
theunhivedmind says:
What a coincidence we have an increase of Dengue Fever that is more severe due to GM mosquitoes right at the same time a new vaccine comes forth. As usual this is no coincidence. I’d rather take my chances with dengue than put this poison chemical puss in my body.
-= The Unhived Mind
Brazil Announces Dengue Fever Emergency in GMO Mosquito Trial Areas
Brazil Announces Dengue Fever Emergency in GMO Mosquito Trial Areas
Brazil Announces Dengue Fever Emergency in GMO Mosquito Trial Areas
by Christina Sarich
July 9th, 2014
Updated 07/09/2014 at 12:13 am
http://naturalsociety.com/brazil-announces-dengue-fever-emergency-gmo-mosquito-trial-areas/
Natural Society reported back in February that a UK company was planning to release GMO mosquitoes in Panama in order to reduce the populations of dengue fever, but now civil society groups in a town in Brazil where GMO trial mosquitoes were released are expressing alarm at an increase in dengue incidence, leading them to declare an emergency decree.
Brazilians were promised that the GM mosquitoes would end dengue fever, but results from field trials conducted in Bahia, Brazil were never published and did not evaluate the relation between Aedes aegypti mosquito populations and the occurrence of dengue. According to a Cambridge University study:
“. . . the targeted mosquitoes may simply move to another area and/or a different species of mosquito (Aedes albopictus) which also transmits dengue can move into the area. Complex immune responses to the four types of dengue virus mean that a partial reduction in mosquito numbers can reduce cross-immunity to the different serotypes and increase the number of cases of the severe form of the disease, Dengue Haemorrhagic Fever, which is more likely to be fatal.”
Without adequate scientific inquiry, the Brazilian regulator Comissão Técnica Nacional de Biossegurança (CTNBio) recently gave the green light to the commercialization of the technology proposed by Moscamed Brazil in partnership with the English company Oxitec and the Universidade de São Paulo. This is the same company that proposed releasing GM mosquitoes in Panama, for supposed similar reasons.
While it is understandable that municipalities with high dengue sickness rates would be interested in lessening the disease, it seems that biotech has once again fooled government agencies into polluting the environment with untested, unsafe, genetically manipulated organisms.
Once again, government officials ignored warnings that GM mosquitoes might be hazardous to public health. During the evaluation of the commercial application for the release of the GM mosquito, The National Technical Commission for Biosecurity (CTNBio) member had presented a report with information questioning the impact of the GM mosquitoes on the incidence of dengue, warning that in some circumstances the releases could make the disease worse, even if the number of wild Aedes aegypti mosquitoes was reduced. CTNBio approved Oxitec’s dengue ‘solution,’ nevertheless.
The Brazilian press even lauded the new weapon to combat dengue, but failed to print information that Jacobina’s mayor, a locality where the GMO mosquito trials took place, issued a decree in February 2014 renewing the state of emergency “due to the abnormal situation characterized as a biological disaster of dengue epidemic.”
Previously, Moscamed had announced an 81% and a 100% reduction in the number of Aedes aegypti mosquitoes in at least two localities of Jacobina, claiming that this meant the experiments were a success. According to Oxitec, pilot-scale releases started in the north-west of Jacobina in June 2013 and the programe would roll out across the entire city over two or three years.
The latest state of dengue emergency can be linked to the GMO mosquitoes, since the instance of disease is greatest in areas where they were released. The Brazilian National Agency of Sanitary Vigilance (ANVISA) is now in charge of registering and monitoring the product. Over 10 million GM mosquitoes are suggested for release for every 50 thousand inhabitants by the makers of the latest GM atrocity.